
Wei ZhangLiving
Novo Nordisk Introduces Higher-Dose Semaglutide in Thailand
The Danish drugmaker presented the formulation to more than 500 medical practitioners to address cardiovascular-kidney-metabolic syndrome.
Tag
1 story in this topic

The Danish drugmaker presented the formulation to more than 500 medical practitioners to address cardiovascular-kidney-metabolic syndrome.
Weekly Briefing
Monday, Wednesday and a Friday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.
Read by retail operators, investors and brand teams across Asia.